Literature DB >> 26985745

The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients.

Ngan N Lam1, S Joseph Kim, Gregory A Knoll, Eric McArthur, Krista L Lentine, Kyla L Naylor, Alvin H Li, Salimah Z Shariff, Christine M Ribic, Amit X Garg.   

Abstract

BACKGROUND: Cardiovascular death remains the leading cause of mortality in kidney transplant recipients. Cardiovascular events are associated with significant morbidity. However, current trends in cardiovascular events after kidney transplantation are poorly understood.
METHODS: We conducted a retrospective study using healthcare databases in Ontario, Canada, to determine whether the incidence of cardiovascular events after kidney transplantation has changed from 1994 to 2009. Our primary endpoint was a 3-year composite outcome of posttransplant death or major cardiovascular event (myocardial infarction, coronary angioplasty, coronary artery bypass graft surgery, stroke).
RESULTS: Recipients (n = 4954) were older and had more baseline comorbidity in recent years. A total of 445 recipients (9.0%) died or experienced a major cardiovascular event within 3 years of transplantation. There was no significant change in the incidence of the composite outcome or death-censored cardiovascular events over time (P = 0.41 and 0.92, respectively). After adjusting for age, sex, and comorbidities, the risk of death or major cardiovascular event steadily declined across the years of transplant (2006-2009 adjusted hazard ratio, 0.70; P = 0.009; referent 1994-1997). When recipients were matched on age, sex, and date of cohort entry to members of the general population and to the chronic kidney disease population, the risk was lowest in the general population and highest in the chronic kidney disease population.
CONCLUSION: Despite transplant centers accepting recipients who are older with more comorbidities in recent years, the 3-year cumulative incidence of death or major cardiovascular event has remained stable over time.

Entities:  

Mesh:

Year:  2017        PMID: 26985745     DOI: 10.1097/TP.0000000000001155

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  25 in total

1.  Risk factors for fracture in adult kidney transplant recipients.

Authors:  Kyla L Naylor; Guangyong Zou; William D Leslie; Anthony B Hodsman; Ngan N Lam; Eric McArthur; Lisa-Ann Fraser; Gregory A Knoll; Jonathan D Adachi; S Joseph Kim; Amit X Garg
Journal:  World J Transplant       Date:  2016-06-24

2.  Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops.

Authors:  Allison Tong; John Gill; Klemens Budde; Lorna Marson; Peter P Reese; David Rosenbloom; Lionel Rostaing; Germaine Wong; Michelle A Josephson; Timothy L Pruett; Anthony N Warrens; Jonathan C Craig; Benedicte Sautenet; Nicole Evangelidis; Angelique F Ralph; Camilla S Hanson; Jenny I Shen; Kirsten Howard; Klemens Meyer; Ronald D Perrone; Daniel E Weiner; Samuel Fung; Maggie K M Ma; Caren Rose; Jessica Ryan; Ling-Xin Chen; Martin Howell; Nicholas Larkins; Siah Kim; Sobhana Thangaraju; Angela Ju; Jeremy R Chapman
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

3.  FGF23 and Cardiovascular Structure and Function in Advanced Chronic Kidney Disease.

Authors:  Arvin Halim; Heather N Burney; Xiaochun Li; Yang Li; Claudia Tomkins; Andrew M Siedlecki; Tzong-Shi Lu; Sahir Kalim; Ravi Thadhani; Sharon Moe; Stephen M S Ting; Daniel Zehnder; Thomas F Hiemstra; Kenneth Lim
Journal:  Kidney360       Date:  2022-07-05

4.  Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.

Authors:  Vikas R Dharnidharka; Abhijit S Naik; David Axelrod; Mark A Schnitzler; Huiling Xiao; Daniel C Brennan; Dorry L Segev; Henry Randall; Jiajing Chen; Bertram Kasiske; Krista L Lentine
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

5.  Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study.

Authors:  Masayoshi Okumi; Yoichi Kakuta; Kohei Unagami; Ryoichi Maenosono; Katsunori Miyake; Junpei Iizuka; Toshio Takagi; Hideki Ishida; Kazunari Tanabe
Journal:  Clin Exp Nephrol       Date:  2017-11-20       Impact factor: 2.801

6.  Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation.

Authors:  Shaifali Sandal; Sunjae Bae; Mara McAdams-DeMarco; Allan B Massie; Krista L Lentine; Marcelo Cantarovich; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-12-06       Impact factor: 8.086

7.  Study of Cardiovascular Outcomes in Renal Transplantation: A Prospective, Multicenter Study to Determine the Incidence of Cardiovascular Events in Renal Transplant Recipients in Ontario, Canada.

Authors:  Christine M Ribic; David Holland; John Howell; Anthony Jevnikar; S Joseph Kim; Greg Knoll; Brenda Lee; Jeffrey Zaltzman; Azim S Gangji
Journal:  Can J Kidney Health Dis       Date:  2017-06-14

8.  Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States.

Authors:  Amit K Mathur; Yu-Hui Chang; D Eric Steidley; Raymond Heilman; Narjeet Khurmi; Nabil Wasif; David Etzioni; Adyr A Moss
Journal:  Transplant Direct       Date:  2017-01-16

9.  Immunosuppression Considerations for Older Kidney Transplant Recipients.

Authors:  Wisit Cheungpasitporn; Krista L Lentine; Jane C Tan; Matthew Kaufmann; Yasar Caliskan; Suphamai Bunnapradist; Ngan N Lam; Mark Schnitzler; David A Axelrod
Journal:  Curr Transplant Rep       Date:  2021-04-06

10.  Simultaneous heart-kidney transplantation results in respectable long-term outcome but a high rate of early kidney graft loss in high-risk recipients - a European single center analysis.

Authors:  Oliver Beetz; Juliane Thies; Murat Avsar; Gerrit Grannas; Clara A Weigle; Fabio Ius; Michael Winkler; Christoph Bara; Nicolas Richter; Jürgen Klempnauer; Gregor Warnecke; Axel Haverich
Journal:  BMC Nephrol       Date:  2021-07-09       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.